Introduction
Beta-ray hazards exist in the nuclear power industry, in the processing of radioactive ore, in medical, industrial and research applications of radioactive isotopes and around accelerators. While measurements of beta-ray doses have been routine for more than 40 years, the accuracy and reliability of beta-ray dosimetry have always lagged behind those of gammaray dosimetry. This can be attributed partly to the special technical difficulties of measuring beta-ray doses and partly to the fact that, under normal working conditions, beta radiation usually constitutes a smaller overall risk to personnel than does gamma radiation. Hence, there has been greater incentive to improve gamma dosimetry. This difference arises mainly because it is much easier to shield against beta radiation. There are, however, a number of industrial and medical situations where it is necessary to handle unshielded or lightly-shielded radioactive material and where beta-ray hazards are particularly important. Beta-ray doses from a thin, unshielded source may be more than 50 times larger than the gamma-ray doses from the same source.
The importance of accurately assessing beta-ray hazards is greatly increased after an accidental release of radioactive material, when it may be necessary to work in intense beta-ray fields in order to clean up the radioactive contamination on exposed surfaces. An extreme example of such a situation is the Chernobyl accident, where a number of workers received beta-ray doses that contributed substantially to their deaths (IAEA,1986) .
One of the principal difficulties of determining beta-ray doses and their significance comes from the large variations of dose over short distances. Within tissue, this arises from the strong attenuation of beta radiation. An example is the dose distribution from beta contamination on the surface of the skin. In addition, the skin (particularly on the hands) is often irradiated by small-area sources at very short distances from the surface. Such doses may therefore be extremely nonuniform just for geometrical reasons. An equally important difficulty is the need to measure doses in a very thin layer, such as that of basal cells in the skin. To simulate such volumes, a detector must be extremely thin, with consequent reduction in sensitivity. These problems are complicated by the strong scattering of beta radiation in air, which results in significant changes in the energy and angular characteristics of a beta-ray beam with varying distance from the source.
The general aim of beta-ray dosimetry in radiation protection is to provide dosimetric information that will help in keeping any harmful effects of beta rays within acceptable limits and that, in the event of serious over-exposure, will assist medical treatment and prognosis. The present report is intended to outline the biological basis for beta-ray dose limitations, to describe the techniques for measuring betaray doses or calculating them for known sources, and to provide physical data needed for such determinations.
ICRU reports have not previously been concerned specifically with beta-ray dosimetry. ICRU 35 Report (ICRU, 1984a) deals with the dosimetry of highenergy electron beams. This differs from the dosimetry of beta radiation in several important respects:
(1) the doses to be determined are delivered to a patient in a well-defined, parallel beam under controlled conditions, whereas, for beta radiation, the angular distribution is highly variable and often unknown, (2) the variation of dose with depth is much less and the volumes in which doses are to be determined are much larger, (3) most of the energy range considered lies well above that of beta rays, and (4) the beams are nearly monoenergetic and of known energy. As a result, the measurement techniques and many of the calculations are quite different from those used for beta-ray dosimetry.
The scope of this report is limited to beta rays and electrons from sources external to the body, including contamination on the skin; the determination of doses from internal sources involves very different techniques and calculations. Only dosimetry related to radiation protection is considered here, and not that for therapeutic medical irradiations. Accidental doses from beams of high-energy electrons are best determined by the techniques and calculations used for electron-beam therapy and will not be treated here. This report is concerned with beta rays mostly with maximum energies up to about 4 MeV. Gamma radiation is considered only when it affects the determination of beta-ray doses.
